Synergy CHC Corp. said it received a Nasdaq non-compliance notice after missing the deadline to file its quarterly report on Form 10-Q for the period ended June 30, 2026.
The notice, issued under Nasdaq Listing Rule 5250(c)(1), does not immediately affect the trading status of the company’s common stock on the Nasdaq exchange. Synergy CHC, which markets FOCUSfactor brain health supplements and Flat Tummy women’s wellness products through retailers including Walmart, Amazon, BJ’s, and Walgreens, must now submit a compliance plan to Nasdaq within 60 calendar days.
The deadline for the compliance plan is October 19, 2026. Nasdaq may, at its discretion, grant an extension of up to 180 calendar days from the original filing due date, which would extend the compliance window to February 10, 2027. Synergy CHC said it cannot predict whether it will file the overdue report or regain compliance.
The company is headquartered in North Windham, Maine, and operates in the United States, Canada, and Mexico. Its stock trades under the ticker SNYR on the Nasdaq.
